Alcon AG | ALC - Cash And Equivalent

Stock Price
60.07
Daily Change
-1.13 -1.85%
Monthly
-6.02%
Yearly
-24.67%
Q1 Forecast
59.31

Alcon AG reported $1.5B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AstraZeneca USD 8.14B 1.08B Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Essilor EUR 2.79B 535M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 2.25B 1.08B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sonova Holding CHF 413.9M 134.3M Jun/2023
UCB EUR 1.57B 1.14B Dec/2024